Owner Merck Patent GmbH

Inventors Kluxen, Franz-Werner; Hentsch, Bernd; Ehring, Thomas; Brandle, Marian; Hoheisel, Jorg Dietrich; Frohme, Marcus; Zubakov, Dimitri

Agent Davies Collison Cave

Pub. Number AU-B-2009201627

Parent 2002352201

Filing date 24 April 2009

Wipo publication date 21 May 2009

Acceptance publication date 6 September 2012

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/04 Drugs for disorders of the cardiovascular system

A61P 9/10 Drugs for disorders of the cardiovascular system

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids